Literature DB >> 27708120

Commercial Dairy Cow Milk microRNAs Resist Digestion under Simulated Gastrointestinal Tract Conditions.

Abderrahim Benmoussa1, Chan Ho C Lee1, Benoit Laffont1, Patricia Savard2, Jonathan Laugier1, Eric Boilard1, Caroline Gilbert1, Ismail Fliss2, Patrick Provost3.   

Abstract

BACKGROUND: MicroRNAs are small, gene-regulatory noncoding RNA species present in large amounts in milk, where they seem to be protected against degradative conditions, presumably because of their association with exosomes.
OBJECTIVE: We monitored the relative stability of commercial dairy cow milk microRNAs during digestion and examined their associations with extracellular vesicles (EVs).
METHODS: We used a computer-controlled, in vitro, gastrointestinal model TNO intestinal model-1 (TIM-1) and analyzed, by quantitative polymerase chain reaction, the concentration of 2 microRNAs within gastrointestinal tract compartments at different points in time. EVs within TIM-1 digested and nondigested samples were studied by immunoblotting, dynamic light scattering, quantitative polymerase chain reaction, and density measurements.
RESULTS: A large quantity of dairy milk Bos taurus microRNA-223 (bta-miR-223) and bta-miR-125b (∼109-1010 copies/300 mL milk) withstood digestion under simulated gastrointestinal tract conditions, with the stomach causing the most important decrease in microRNA amounts. A large quantity of these 2 microRNAs (∼108-109 copies/300 mL milk) was detected in the upper small intestine compartments, which supports their potential bioaccessibility. A protocol optimized for the enrichment of dairy milk exosomes yielded a 100,000 × g pellet fraction that was positive for the exosomal markers tumor susceptibility gene-101 (TSG101), apoptosis-linked gene 2-interacting protein X (ALIX), and heat shock protein 70 (HSP70) and containing bta-miR-223 and bta-miR-125b. This approach, based on successive ultracentrifugation steps, also revealed the existence of ALIX-, HSP70-/low, and TSG101-/low EVs larger than exosomes and 2-6 times more enriched in bta-miR-223 and bta-miR-125b (P < 0.05).
CONCLUSIONS: Our findings indicate that commercial dairy cow milk contains numerous microRNAs that can resist digestion and are associated mostly with ALIX-, HSP70-/low, and TSG101-/low EVs. Our results support the existence of interspecies transfer of microRNAs mediated by milk consumption and challenge our current view of exosomes as the sole carriers of milk-derived microRNAs.
© 2016 American Society for Nutrition.

Entities:  

Keywords:  TIM-1; digestion; exosome; extracellular vesicles; microRNA; milk

Mesh:

Substances:

Year:  2016        PMID: 27708120     DOI: 10.3945/jn.116.237651

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  63 in total

1.  Concentrations of Purine Metabolites Are Elevated in Fluids from Adults and Infants and in Livers from Mice Fed Diets Depleted of Bovine Milk Exosomes and their RNA Cargos.

Authors:  Ana Aguilar-Lozano; Scott Baier; Ryan Grove; Jiang Shu; David Giraud; Amy Leiferman; Kelly E Mercer; Juan Cui; Thomas M Badger; Jiri Adamec; Aline Andres; Janos Zempleni
Journal:  J Nutr       Date:  2018-12-01       Impact factor: 4.798

2.  Are Dietary Extracellular Vesicles Bioavailable and Functional in Consuming Organisms?

Authors:  Rahul Sanwlani; Pamali Fonseka; Suresh Mathivanan
Journal:  Subcell Biochem       Date:  2021

3.  The Potential of Exosomes From Cow Milk for Oral Delivery.

Authors:  Jamie L Betker; Brittany M Angle; Michael W Graner; Thomas J Anchordoquy
Journal:  J Pharm Sci       Date:  2018-11-20       Impact factor: 3.534

4.  Platelets Disseminate Extracellular Vesicles in Lymph in Rheumatoid Arthritis.

Authors:  Nicolas Tessandier; Imene Melki; Nathalie Cloutier; Isabelle Allaeys; Adam Miszta; Sisareuth Tan; Andreea Milasan; Sara Michel; Abderrahim Benmoussa; Tania Lévesque; Francine Côté; Steven E McKenzie; Caroline Gilbert; Patrick Provost; Alain R Brisson; Alisa S Wolberg; Paul R Fortin; Catherine Martel; Éric Boilard
Journal:  Arterioscler Thromb Vasc Biol       Date:  2020-02-27       Impact factor: 8.311

5.  A diet defined by its content of bovine milk exosomes and their RNA cargos has moderate effects on gene expression, amino acid profiles and grip strength in skeletal muscle in C57BL/6 mice.

Authors:  Amy Leiferman; Jiang Shu; Ryan Grove; Juan Cui; Jiri Adamec; Janos Zempleni
Journal:  J Nutr Biochem       Date:  2018-06-12       Impact factor: 6.048

6.  NIH workshop on human milk composition: summary and visions.

Authors:  Kellie O Casavale; Jaspreet K C Ahuja; Xianli Wu; Ying Li; Julia Quam; Richard Olson; Pamela Pehrsson; Lindsay Allen; Douglas Balentine; Manjit Hanspal; Deborah Hayward; Erin Pias Hines; James P McClung; Cria G Perrine; Mandy Brown Belfort; David Dallas; Bruce German; Jae Kim; Mark McGuire; Michelle McGuire; Ardythe L Morrow; Margaret Neville; Laurie Nommsen-Rivers; Kathleen M Rasmussen; Janos Zempleni; Christopher J Lynch
Journal:  Am J Clin Nutr       Date:  2019-09-01       Impact factor: 7.045

7.  Milk Exosomes Prevent Intestinal Inflammation in a Genetic Mouse Model of Ulcerative Colitis: A Pilot Experiment.

Authors:  Wolfgang Stremmel; Ralf Weiskirchen; Bodo C Melnik
Journal:  Inflamm Intest Dis       Date:  2020-05-20

8.  RNase H2-Dependent Polymerase Chain Reaction and Elimination of Confounders in Sample Collection, Storage, and Analysis Strengthen Evidence That microRNAs in Bovine Milk Are Bioavailable in Humans.

Authors:  Lanfang Wang; Mahrou Sadri; David Giraud; Janos Zempleni
Journal:  J Nutr       Date:  2018-01-01       Impact factor: 4.798

Review 9.  Exosomes in Food: Health Benefits and Clinical Relevance in Diseases.

Authors:  Javaria Munir; Mihye Lee; Seongho Ryu
Journal:  Adv Nutr       Date:  2020-05-01       Impact factor: 8.701

10.  MicroRNA profiling of gastric content from breast-fed and formula-fed infants to estimate last feeding: a pilot study.

Authors:  Yu Kakimoto; Yutaka Matsushima; Masayuki Tanaka; Hideki Hayashi; Ting Wang; Keiko Yokoyama; Eriko Ochiai; Motoki Osawa
Journal:  Int J Legal Med       Date:  2019-12-12       Impact factor: 2.686

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.